C18 3'-sulfo Galactosylceramide (d18:1/18:0) [244215-65-4]
Referencia NB-64-25921-1mg
embalaje : 1mg
Marca : Neo Biotech
Contact local distributor :
Teléfono : +1 850 650 7790
C18 3'-sulfo Galactosylceramide (d18:1/18:0) (Synonyms: C18 3'-sulfo Galactosylceramide (d18:1/18:0))
Catalog No. T38183 Copy Product Info
C18 3'-sulfo Galactosylceramide is a member of the sulfatide class of glycolipids. Levels of short-chain sulfatides, including C18 3'-sulfo galactosylceramide, decrease with age in mice and humans. It is increased in brain from mice with an arylsulfatase A deficiency (ASA-KO), particularly in lipid raft fractions. Plasma levels of C18 3'-sulfo galactosylceramide positively correlate with disability progression in patients with relapsing-remitting multiple sclerosis using the Expanded Disability Status Scale. It is also increased in plasma from patients with metachromatic leukodystrophy (MLD).
C18 3'-sulfo Galactosylceramide (d18:1/18:0)
Copy Product InfoSynonyms C18 3'-sulfo Galactosylceramide (d18:1/18:0)
C18 3'-sulfo Galactosylceramide is a member of the sulfatide class of glycolipids. Levels of short-chain sulfatides, including C18 3'-sulfo galactosylceramide, decrease with age in mice and humans. It is increased in brain from mice with an arylsulfatase A deficiency (ASA-KO), particularly in lipid raft fractions. Plasma levels of C18 3'-sulfo galactosylceramide positively correlate with disability progression in patients with relapsing-remitting multiple sclerosis using the Expanded Disability Status Scale. It is also increased in plasma from patients with metachromatic leukodystrophy (MLD).
Cas No. 244215-65-4
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | C18 3'-sulfo Galactosylceramide is a member of the sulfatide class of glycolipids. Levels of short-chain sulfatides, including C18 3'-sulfo galactosylceramide, decrease with age in mice and humans. It is increased in brain from mice with an arylsulfatase A deficiency (ASA-KO), particularly in lipid raft fractions. Plasma levels of C18 3'-sulfo galactosylceramide positively correlate with disability progression in patients with relapsing-remitting multiple sclerosis using the Expanded Disability Status Scale. It is also increased in plasma from patients with metachromatic leukodystrophy (MLD). |
| Synonyms | C18 3'-sulfo Galactosylceramide (d18:1/18:0) |
| Molecular Weight | 808.17 |
| Formula | C42H81NO11S |
| Cas No. | 244215-65-4 |
| Smiles | CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OS(O)(=O)=O)[C@H]1O)[C@H](O)\C=C\CCCCCCCCCCCCC |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | Chloroform:Methanol (5:1): Soluble |